- Q82.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM Q82.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Q82.2 – other international versions of ICD-10 Q82.2 may differ.
ICD-10-CM Q82.2 is grouped within Diagnostic Related Group(s):
Applicable To
- Congenital diffuse cutaneous mastocytosis
- Congenital maculopapular cutaneous mastocytosis
- Congenital urticaria pigmentosa
Type 1 Excludes
- cutaneous mastocytosis NOS (D47.01)
- diffuse cutaneous mastocytosis (with onset after newborn period) (D47.01)
- malignant mastocytosis (C96.2-)
- systemic mastocytosis (D47.02)
- urticaria pigmentosa (non-congenital) (with onset after newborn period) (D47.01)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to Q82.2:
- congenital > cutaneous (diffuse) (maculopapular) D47.01
- of neonatal onset > cutaneous (diffuse) (maculopapular) D47.01
- of newborn onset > cutaneous (diffuse) (maculopapular) D47.01
- congenital > pigmentosa D47.01
- of neonatal onset > pigmentosa D47.01
- of newborn onset > pigmentosa D47.01